US 12,009,086 B2
Systems and methods for disease control and management
Ryan A. Sysko, Wilmington, DE (US); Suzanne K. Sysko, Wilmington, DE (US); James M. Minor, Newark, DE (US); Anand K. Iyer, Potomac, MD (US); and Andrew V. Fletcher, Park City, UT (US)
Assigned to Welldoc, Inc., Columbia, MD (US)
Filed by Welldoc, Inc., Columbia, MD (US)
Filed on May 23, 2023, as Appl. No. 18/321,821.
Application 18/321,821 is a continuation of application No. 17/224,489, filed on Apr. 7, 2021, granted, now 11,699,511.
Application 17/224,489 is a continuation of application No. 17/074,194, filed on Oct. 19, 2020, granted, now 11,004,558, issued on May 11, 2021.
Application 17/074,194 is a continuation of application No. 16/186,996, filed on Nov. 12, 2018, granted, now 10,818,389, issued on Oct. 27, 2020.
Application 16/186,996 is a continuation of application No. 15/670,551, filed on Aug. 7, 2017, abandoned.
Application 15/670,551 is a continuation of application No. 12/071,486, filed on Feb. 21, 2008, granted, now 9,754,077, issued on Sep. 5, 2017.
Claims priority of provisional application 60/902,490, filed on Feb. 22, 2007.
Prior Publication US 2023/0290481 A1, Sep. 14, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 20/60 (2018.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 50/50 (2018.01); G16H 70/20 (2018.01)
CPC G16H 20/60 (2018.01) [G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 50/50 (2018.01); G16H 70/20 (2018.01)] 20 Claims
OG exemplary drawing
 
1. An adaptive analytical behavioral health assistant system, comprising:
a physical biometric measurement device configured to obtain biometric measurements from a user, and to wirelessly transmit the obtained biometric measurements, the physical biometric measurement device selected from one or more of a scale, an external blood pressure monitor, a cardiac data sensor, an implantable blood glucose sensor for continuous sensing, an external blood glucose monitor, a blood pressure measuring device for measuring blood pressure measurements of the user, or a weight measuring device for measuring weight measurements of the user;
an insulin-delivery device configured to output at least insulin intake amounts and insulin intake times in connection with insulin doses administered to the user; and
a disease management server in wireless communication with the physical biometric measurement device and the insulin-delivery device, the disease management server including:
a receiver configured to receive the transmitted biometric measurements from the physical biometric measurement device and the insulin intake amounts and the insulin intake times from the insulin-delivery device; and
one or more processors configured to:
generate a user specific model of a physiological system of the user, by modifying a basic model of a physiological system generic to any user using at least physiological data of the user, the user specific model being based on a plurality of parameters of the physiological system of the user, the plurality of parameters including an insulin intake amount, an insulin intake time, a glucose level, and a time of measurement of glucose level;
execute the user specific model to generate one or more instructions, as part of a treatment recommendation, relating to adjusting a dose of insulin and to generate personalized notifications, which comprise the treatment recommendation further based on the physiological system of the user, the instructions relating to adjusting the dose of insulin and the personalized notifications being based on the user specific model and the received biometric measurements of the user and the received insulin intake amounts and the insulin intake times;
output the instructions relating to adjusting the dose of insulin directly to the insulin-delivery device; and
output the personalized notifications to at least the physical biometric measurement device,
wherein the physical biometric measurement device is further configured to receive the personalized notifications, and to modify an internal signal to output the personalized notifications to the user, and
wherein the insulin-delivery device is further configured to receive the instructions relating to adjusting the dose of insulin, to adjust the dose of insulin, and to administer the adjusted dose of insulin.